Editor's note: In its recent Fumigants & Pheromones enewsletter, Insects Limited included its annual list of the Top 15 Clothes Moth Cities in the U.S.
For 2019, the top four cities for clothes moth remain unchanged; New York City, Boston, Philadelphia and Los Angeles. Minneapolis inched up two spots to grab the final spot in the top five. The state of Texas made big leaps this year as Dallas moved up considerably, and Houston joined the list while Atlanta dropped off.
Eastern Seaboard. The Eastern Seaboard again owns the top three spots on this list with NYC, Boston and Philadelphia highlighting those spots.
Other cities. Los Angeles remained steady at the No. 4 spot. Denver tied with Dallas by moving up four spots from 13th to 9th. Washington DC was the biggest mover overall on the list, dropping from the 5th spot to the 12th. Chicago moved up from 8th to 6th.
Texas. Moth populations in Texas look like they are on the rise with Dallas moving from 11th to 7th on the list and Houston coming out of nowhere and moving right into the 11th spot.
Webbing clothes moth, Tineola bisselliella, appear to continue to be on a rapid rise in many metropolitan areas. Research has suggested that the webbing clothes moth does not come into our homes and businesses from natural reservoirs (E.g. bird nests, dead animals) but instead travels from person to person1.
This type of behavior is called synanthropic, which means the clothes moths benefit from an association with humans and the habitats that humans create. As we pass along our wool rugs, blankets, sweaters, fur coats and feather pillows, etc. to family members, friends or other means of trade, we also move the moths from location to location. The densely populated northern portion of the Eastern Seaboard (Maine to Washington DC) again accounted for over 70% of the clothes moth sales for the entire country. As people move about the country, they carry the clothes moths with them, so even if your city isn’t on this list now, be prepared because they still might be coming your way soon!
In response to the COVID-19 outbreak, FDA has postponed most foreign inspections through April. Inspections outside the U.S. deemed
FDA based the decision on the State Department Level 4 travel advisories in which travel is prohibited for U.S. government employees; CDC travel recommendations; access restrictions being imposed on foreign visitors by certain countries; guidance from the Office of Personnel Management; and the importance of the health and safety of its employees. “Another critical factor in taking this action is the confidence we have in our ability to maintain oversight over international manufacturers and imported products using alternative tools and methods,” the FDA statement said, adding, “We are aware of how this action may impact other FDA responsibilities, including product application reviews. We will be vigilant and monitor the situation very closely and will try to mitigate potential impacts from this outbreak in lockstep with the whole of the federal government. We stand ready to resume foreign inspections as soon as feasible.”
As an interim measure, FDA is employing additional tools to ensure the safety of products imported to the U.S., including denying entry of unsafe products into the U.S., physical examinations and/or product sampling at our borders, reviewing a firm’s previous compliance history, using information sharing from foreign governments as part of mutual recognition, and confidentiality agreements and requesting records “in advance of or in lieu of” on-site drug inspections. FDA exercised this authority when it postponed on-the-ground inspections of manufacturers of FDA-regulated products in China earlier in the outbreak.
FDA will continue working with U.S. Customs and Border Protection to target products intended for importation into the U.S. that violate applicable legal requirements for FDA-regulated products, which may come from a variety of sources, such as first-time importers unfamiliar with regulatory requirements or repeat offenders trying to skirt the law. The agency also has the ability through our risk-based import screening tool (PREDICT) to focus its examinations and sample collections based on heightened concerns of specific products being entered into U.S. commerce. The PREDICT screening continues to adjust risk scores as necessary throughout the COVID-19 outbreak. FDA also is keeping a close eye out for indications of port shopping or cargo diversion and will continue our oversight of shipments through potentially higher-risk venues such as International Mail Facilities. The agency can refuse admission of products that fail sample testing or may violate other applicable legal requirements.
As this remains a dynamic situation, the agency will continue to assess and calibrate its approach as needed to help advance federal response efforts in the fight against this outbreak.
Cherney Microbiological Services, Ltd. announced the launch of two new environmental monitoring focused proficiency programs. The Environmental Indicator Organism and Environmental Pathogen programs utilize common organisms targeted in environmental monitoring programs. Using a polyurethane sponge as the sample matrix, participation in these programs ensures the confidence of your environmental monitoring results, the company said. Enrollment for both programs is now available for the remainder of 2020.
The two environmental monitoring based proficiency programs will support the proactive approach to food safety by ensuring the validity of environmental monitoring results, the company said, adding, that these are taken to obtain a more encompassing picture of microbial risks in the manufacturing environment than that provided by product testing alone.
For more information and to enroll visit https://www.cherneymicro.com/proficiency-programs-1 or contact firstname.lastname@example.org or 920-406-8300.
MADISON, WI – Bell’s fastest acting rodenticide is now available to pest management professionsals (PMPs) in a new form: Fastrac Soft Bait.
Fastrac Soft Bait offers the palatability and acceptance of Bell’s Fastrac Blox bromethalin rodenticide, now in a unique oil-based formulation with a precise balance between saturated and unsaturated fats. Fastrac Soft Bait is also designed to withstand almost any climate. In cold climates, the bait won’t freeze and when temperatures and humidity rise, Fastrac Soft Bait is both mold- and heat-resistant, according to Bell Laboratories.
The fast-acting bromethalin active ingredient paired with the palatability of Bell’s proprietary soft bait formulation will help PMPs knock down rodent infestations at accounts quickly. Bell Labs reports that technicians will use less bait versus anticoagulants and see faster results, as rodents can consume a lethal dose in a single night’s feeding, which reduces the amount of bait required to achieve control. “Bell is excited to provide another tool for PMPs. With the success and high acceptance of Contrac Soft Bait, it made sense to offer our winning formulation with an acute active ingredient,” says Kate Van Boxel, senior brand manager, Bell Laboratories.
Fastrac Soft Bait is available in a 4 lb. pail size. This new Soft Bait pail is clearly differentiated from all other Bell Laboratories pails with a purple lid for ease of identification by distributors and PMPs. Fastrac Soft Bait is available in 8 g sachets with a minimum mouse placement of 1 sachet and a minimum rat placement of 4 sachets.
To learn more, visit www.belllabs.com.